Free intracellular methotrexate is a critical factor in the inhibition of dihydrofolate reduction in Ehrlich ascites tumor cells in vitro

J. C. White, I. David Goldman

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

It was previously reported that maximal suppression of deoxyuridine incorporation into DNA requires exchangeable methotrexate (MTX(ex)), i.e. intracellular MTX in excess of the tightly bound fraction, (MTX(b)). Further, MTX(ex) is required to suppress 14C formate incorporation into DNA, RNA and protein as well, suggesting that in the presence of MTX(b) alone adequate tetrahydrofolate (THF) cofactor levels may be maintained. We now describe the effects of MTX(b) and MTX(ex) on the reduction of folic acid (FA) and DHF in intact cells. Cells were incubated with or without MTX to saturate high affinity sites then the MTX treated cells were divided into two portions, one incubated without MTX to allow efflux of MTX(ex) and the other continued in MTX. The three cell portions were then incubated with 3H FA or 3H DHF, sonicated, and the soluble radiolabelled components separated by DEAE cellulose chromatography. Reduction of 3H FA was markedly decreased by MTX(b) alone; although a small level of residual THF synthesis persisted, this was completely eliminated by MTX(ex). MTX(b) alone had little effect on 3H DHF reduction; but THF synthesis was abolished when MTX(ex) was 5 μM. The data indicate that MTX(ex) is required to inhibit DHF reduction in these cells in vitro. The high levels of MTX(ex) achieved with high dose infusions may contribute to the increased cytotoxicity of these regimens.

Original languageEnglish (US)
Title of host publicationProceedings of the American Association for Cancer Research
Volume16
Edition66
StatePublished - 1975
Externally publishedYes

Fingerprint

Ehrlich Tumor Carcinoma
Methotrexate
Folic Acid
formic acid
DEAE-Cellulose Chromatography
Deoxyuridine
DNA
dihydrofolate
In Vitro Techniques
RNA
5,6,7,8-tetrahydrofolic acid
Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Free intracellular methotrexate is a critical factor in the inhibition of dihydrofolate reduction in Ehrlich ascites tumor cells in vitro. / White, J. C.; Goldman, I. David.

Proceedings of the American Association for Cancer Research. Vol. 16 66. ed. 1975.

Research output: Chapter in Book/Report/Conference proceedingChapter

@inbook{6948b227c965470d86a080c3a43a8162,
title = "Free intracellular methotrexate is a critical factor in the inhibition of dihydrofolate reduction in Ehrlich ascites tumor cells in vitro",
abstract = "It was previously reported that maximal suppression of deoxyuridine incorporation into DNA requires exchangeable methotrexate (MTX(ex)), i.e. intracellular MTX in excess of the tightly bound fraction, (MTX(b)). Further, MTX(ex) is required to suppress 14C formate incorporation into DNA, RNA and protein as well, suggesting that in the presence of MTX(b) alone adequate tetrahydrofolate (THF) cofactor levels may be maintained. We now describe the effects of MTX(b) and MTX(ex) on the reduction of folic acid (FA) and DHF in intact cells. Cells were incubated with or without MTX to saturate high affinity sites then the MTX treated cells were divided into two portions, one incubated without MTX to allow efflux of MTX(ex) and the other continued in MTX. The three cell portions were then incubated with 3H FA or 3H DHF, sonicated, and the soluble radiolabelled components separated by DEAE cellulose chromatography. Reduction of 3H FA was markedly decreased by MTX(b) alone; although a small level of residual THF synthesis persisted, this was completely eliminated by MTX(ex). MTX(b) alone had little effect on 3H DHF reduction; but THF synthesis was abolished when MTX(ex) was 5 μM. The data indicate that MTX(ex) is required to inhibit DHF reduction in these cells in vitro. The high levels of MTX(ex) achieved with high dose infusions may contribute to the increased cytotoxicity of these regimens.",
author = "White, {J. C.} and Goldman, {I. David}",
year = "1975",
language = "English (US)",
volume = "16",
booktitle = "Proceedings of the American Association for Cancer Research",
edition = "66",

}

TY - CHAP

T1 - Free intracellular methotrexate is a critical factor in the inhibition of dihydrofolate reduction in Ehrlich ascites tumor cells in vitro

AU - White, J. C.

AU - Goldman, I. David

PY - 1975

Y1 - 1975

N2 - It was previously reported that maximal suppression of deoxyuridine incorporation into DNA requires exchangeable methotrexate (MTX(ex)), i.e. intracellular MTX in excess of the tightly bound fraction, (MTX(b)). Further, MTX(ex) is required to suppress 14C formate incorporation into DNA, RNA and protein as well, suggesting that in the presence of MTX(b) alone adequate tetrahydrofolate (THF) cofactor levels may be maintained. We now describe the effects of MTX(b) and MTX(ex) on the reduction of folic acid (FA) and DHF in intact cells. Cells were incubated with or without MTX to saturate high affinity sites then the MTX treated cells were divided into two portions, one incubated without MTX to allow efflux of MTX(ex) and the other continued in MTX. The three cell portions were then incubated with 3H FA or 3H DHF, sonicated, and the soluble radiolabelled components separated by DEAE cellulose chromatography. Reduction of 3H FA was markedly decreased by MTX(b) alone; although a small level of residual THF synthesis persisted, this was completely eliminated by MTX(ex). MTX(b) alone had little effect on 3H DHF reduction; but THF synthesis was abolished when MTX(ex) was 5 μM. The data indicate that MTX(ex) is required to inhibit DHF reduction in these cells in vitro. The high levels of MTX(ex) achieved with high dose infusions may contribute to the increased cytotoxicity of these regimens.

AB - It was previously reported that maximal suppression of deoxyuridine incorporation into DNA requires exchangeable methotrexate (MTX(ex)), i.e. intracellular MTX in excess of the tightly bound fraction, (MTX(b)). Further, MTX(ex) is required to suppress 14C formate incorporation into DNA, RNA and protein as well, suggesting that in the presence of MTX(b) alone adequate tetrahydrofolate (THF) cofactor levels may be maintained. We now describe the effects of MTX(b) and MTX(ex) on the reduction of folic acid (FA) and DHF in intact cells. Cells were incubated with or without MTX to saturate high affinity sites then the MTX treated cells were divided into two portions, one incubated without MTX to allow efflux of MTX(ex) and the other continued in MTX. The three cell portions were then incubated with 3H FA or 3H DHF, sonicated, and the soluble radiolabelled components separated by DEAE cellulose chromatography. Reduction of 3H FA was markedly decreased by MTX(b) alone; although a small level of residual THF synthesis persisted, this was completely eliminated by MTX(ex). MTX(b) alone had little effect on 3H DHF reduction; but THF synthesis was abolished when MTX(ex) was 5 μM. The data indicate that MTX(ex) is required to inhibit DHF reduction in these cells in vitro. The high levels of MTX(ex) achieved with high dose infusions may contribute to the increased cytotoxicity of these regimens.

UR - http://www.scopus.com/inward/record.url?scp=0016793081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016793081&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:0016793081

VL - 16

BT - Proceedings of the American Association for Cancer Research

ER -